· By Sanofi Admin

Black History Month: Building Legacies – Part 2

This post was authored by Tanisha M. Sullivan, Senior Corporate Counsel, Sanofi US, who was recently elected President, National Association for the Advancement of Colored People (NAACP) – Boston Branch. Here, in honor of Black History Month, she shares her story about what led to her election to the association’s oldest chapter, with just under […]

VIEW FULL POST
 · By Sanofi Admin

Black History Month: Building Legacies

This post was authored by Lisa Egbuonu-Davis, M.D., Vice President, Global Patient Centered Outcomes & Solutions, who, in honor of Black History Month, shares her story about why she is committed to supporting gifted students from underrepresented minorities and socioeconomic disadvantaged groups. Lisa is a graduate of the Johns Hopkins School of Medicine and Bloomberg […]

VIEW FULL POST
 · By Sanofi Admin

Drug Development 101: Phase 2 Clinical Trials

Author: Kristin Schuhwerk, VP, Global Head of Clinical Operations, Sanofi
This past November, my colleague Paul Deutsch shared some valuable information about Phase 1 clinical trials, as part of our Drug Development 101 series. Today, I’d like to build on this information by providing some insight on what comes after Phase 1 clinical trials – Phase […]

VIEW FULL POST